State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies

Bron
Current opinion in oncology - ISSN 1040-8746-36:4 (2024) p. 313-319
Auteur(s)

Auranofin repurposing for lung and pancreatic cancer : low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition

Bron
Journal of Experimental and Clinical Cancer Research - ISSN 1756-9966-43:1 (2024) p. 1-15